0.5915
Tenaya Therapeutics Inc Borsa (TNYA) Ultime notizie
Millennium Management LLC Sells 174,447 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Tenaya Therapeutics (NASDAQ:TNYA) and Alpha Cognition (NASDAQ:ACOG) Critical Survey - Defense World
Squarepoint Ops LLC Decreases Stock Position in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Nuveen Asset Management LLC Buys 69,377 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Deutsche Bank AG Acquires 97,318 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Northern Trust Corp Grows Stock Holdings in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Tenaya Therapeutics Appoints New Directors at Annual Meeting - TipRanks
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives $6.25 Average Target Price from Brokerages - Defense World
Price T Rowe Associates Inc. MD Sells 2,892,201 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Tenaya therapeutics SVP Higa Tomohiro sells $615 in stock By Investing.com - Investing.com Nigeria
Tenaya Therapeutics chief medical officer sells $1,300 in stock By Investing.com - Investing.com Nigeria
Tenaya Therapeutics chief medical officer sells $1,300 in stock - Investing.com Australia
Tenaya therapeutics SVP Higa Tomohiro sells $615 in stock - Investing.com
Tenaya Therapeutics Awards Major Stock Options Package: 461K Shares for Strategic New Hires - Stock Titan
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire
Greenlane Renewables Announces First Quarter 2025 Financial Results - The Globe and Mail
Barclays PLC Sells 184,837 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Tenaya Therapeutics (TNYA) to Showcase Key Research at ASGCT 2025 | TNYA Stock News - GuruFocus
Tenaya Therapeutics to Highlight Capsid Engineering, Gene Editing and Manufacturing Research at the ASGCT 28th Annual Meeting - The Manila Times
Tenaya Therapeutics to Present Five Abstracts on Innovative Heart Disease Gene Therapies at ASGCT 2025 Annual Meeting - Nasdaq
Tenaya Therapeutics to Highlight Capsid Engineering, Gene - GlobeNewswire
Hsbc Holdings PLC Purchases New Position in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Equities Analysts Issue Forecasts for TNYA Q2 Earnings - Defense World
Tenaya Therapeutics’ (TNYA) Buy Rating Reiterated at Chardan Capital - Defense World
We're A Little Worried About Tenaya Therapeutics' (NASDAQ:TNYA) Cash Burn Rate - Yahoo Finance
Chardan Capital Maintains Buy Rating for Tenaya Therapeutics (TNYA) | TNYA Stock News - GuruFocus
Tenaya Therapeutics Reports Q1 2025 Financial Results - TipRanks
Tenaya (TNYA) Reports Promising Clinical Trial Developments and Financial Outlook | TNYA Stock News - GuruFocus
Tenaya Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
A Cautious Investment in the Drone Sector - The Globe and Mail
Geode Capital Management LLC Sells 27,419 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Layoff Tracker: Ono Cuts 83 Employees in Massachusetts - BioSpace
Why To Invest In Tenaya Therapeutics Inc (NASDAQ: TNYA) Stock? - Marketing Sentinel
H.C. Wainwright maintains Buy on Tenaya Therapeutics stock By Investing.com - Investing.com South Africa
H.C. Wainwright maintains Buy on Tenaya Therapeutics stock - Investing.com Australia
TNYATenaya Therapeutics, Inc. Latest Stock News & Market Updates - Stock Titan
Tenaya reports progress in ARVC gene therapy study - Investing.com
Tenaya Therapeutics Presents Interim Data from RIDGE™ Natural History and Seroprevalence Study of Adults with PKP2-associated ARVC at Heart Rhythm 2025 - The Manila Times
Tenaya Therapeutics Presents Interim Data from RIDGE™ - GlobeNewswire
Major Breakthrough: 175-Patient ARVC Study Shows 93% Could Benefit from New Gene Therapy Treatment - Stock Titan
Strategy (MSTR) Buys Another $556 Million Worth of Bitcoin - The Globe and Mail
Tenaya Therapeutics faces Nasdaq delisting over share price By Investing.com - Investing.com India
Tenaya Therapeutics faces Nasdaq delisting over share price - Investing.com Australia
Alignment Healthcare to Announce First Quarter 2025 Financial Results and Host Conference Call Thursday, May 1, 2025 - The Globe and Mail
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):